Results 101 to 110 of about 2,752 (194)

Genome-scale CRISPR screening uncovers SRSF6 as a target to sensitize hepatocellular carcinoma to radiotherapy. [PDF]

JHEP Rep
Jiang W, Sui X, Dong D, Jiang L, Zheng X, Wang H, Li B, Hou L, Liang Y, Jia M, Jiang S, Teng H, Wang W.   +12 more
europepmc   +1 more source

Safety analysis of long-acting dual bronchodilator after market approval: a real-world study from FDA Adverse Event Reporting System (FAERS) database. [PDF]

J Thorac Dis
Gao S, Zhuang W, Song Q, Yan D, Chen L, Lai Z, Cheng Y, Yang X, Hu S.   +8 more
europepmc   +1 more source

Development and characterization of an Indacaterol/Tiotropium Bromide composite dry powder inhalation formulation for COPD. [PDF]

Pharm Sci Adv
Wang X, Xu X, Cheng C, Zheng J, Liu W, Xu Y, Xu J, Wu L, Sun X, Wang W, Fang H.   +10 more
europepmc   +1 more source

Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease: From Clinical Trials to Daily Practice

, 2014
Indacaterol was introduced as an agent of the new generation of very long acting beta2-agonists (VLABA) that provides a 24-hour activity of bronchodilation and allows a once-daily OD dosing.
Riario Sforza, Gian G., RIDOLO, Erminia, Incorvaia, Cristoforo, Montagni, Marcello, Riario Sforza, Edoardo   +4 more
core  

Evaluating Arrhythmia Risk in Patients with Chronic Obstructive Pulmonary Disease Treated with Aclidinium/Formoterol Fumarate and Other Inhaled Bronchodilators: A Post-Authorization Safety Study. [PDF]

Int J Chron Obstruct Pulmon Dis
Rebordosa C, Aguado J, Bartsch J, Saigi-Morgui N, Carsin AE, Garcia-Esteban R, Ignatova E, Freedman D, Perez-Gutthann S, Rivero-Ferrer E.   +9 more
europepmc   +1 more source

Neuropeptide and cytokines expression in long COVID-19 related neuropsychological sequelae: insights into NK1R-mediated neuroinflammation and <i>in silico</i> therapeutic targeting. [PDF]

Front Cell Neurosci
Abdullah M, Naz A, Reznikov LR, Qureshi JA, Hasnain A, Obaid A, Ali A.   +6 more
europepmc   +1 more source

The Quantification of Drug Accumulation within Gram-Negative Bacteria. [PDF]

ACS Infect Dis
George A, Shivangi, Bozan A, Spencer K, Terlecky AJ, Ahn YM, Barnett PR, Kreiswirth BN, Freundlich JS.   +8 more
europepmc   +1 more source

Drug-related pulmonary fibrosis: A real-world pharmacovigilance study of the FDA Adverse Event Reporting System. [PDF]

Medicine (Baltimore)
Jian R, Yang L, Guo J, Shi E, Du M, Jin H, Zhen H.   +6 more
europepmc   +1 more source

Efficacy, pharmacokinetics, and safety of nebulized HL231 inhalation solution in patients with chronic obstructive pulmonary disease: a randomized trial. [PDF]

J Thorac Dis
Hu Q, Zhao L, Yang G, Wen F, Xie L, Xiao Z, Chen F, He Q, Bian T, Xiong H, Li F, Yue Y, Li Y, Luo L, Luo Z.   +14 more
europepmc   +1 more source

Airway Response to Dual Bronchodilation and Its Association with Inflammatory Markers in Treatment-Naïve Chronic Obstructive Pulmonary Disease: A Quantitative Computed Tomography Study. [PDF]

Life (Basel)
Dimiene I, Zaveckiene J, Bieksiene K, Vaguliene N, Hoppenot D, Malakauskas K, Zemaitis M, Miliauskas S.   +7 more
europepmc   +1 more source